Search
Dimethylaminopropionylphenothiazine
go.drugbank.com/drugs/DB13672ExperimentalCategories: Alimentary Tract and MetabolismVofatamab
go.drugbank.com/drugs/DB14781InvestigationalVofatamab is under investigation in clinical trial NCT02401542 (Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma).
Categories: Amino Acids, Peptides, and ProteinsPrasinezumab
go.drugbank.com/drugs/DB14788InvestigationalPrasinezumab is under investigation in clinical trial NCT03100149 (A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease).
Categories: Amino Acids, Peptides, and ProteinsOsocimab
go.drugbank.com/drugs/DB14818InvestigationalOsocimab is under investigation in clinical trial NCT03276143 (Factor XIa inhibition for the prevention of venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty).
Categories: Amino Acids, Peptides, and ProteinsIcrucumab
go.drugbank.com/drugs/DB14824InvestigationalIcrucumab is under investigation in clinical trial NCT01111604 (A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer).
Categories: Amino Acids, Peptides, and ProteinsEnoblituzumab
go.drugbank.com/drugs/DB15017InvestigationalEnoblituzumab is under investigation in clinical trial NCT02982941 (Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors).
Categories: Amino Acids, Peptides, and ProteinsNeopterin
go.drugbank.com/drugs/DB15050InvestigationalNeopterin is under investigation in clinical trial NCT02974192 (Neopterin Effects on Ischemic Stroke).
Categories: Enzymes and CoenzymesVunakizumab
go.drugbank.com/drugs/DB15154InvestigationalVunakizumab is under investigation in clinical trial NCT03463187 (Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis).
Categories: Amino Acids, Peptides, and ProteinsFlotetuzumab
go.drugbank.com/drugs/DB15223InvestigationalFlotetuzumab is under investigation in clinical trial NCT02152956 (Safety Study of MGD006 in Relapsed/Refractory Acute Myeloid Leukemia (AML) or Intermediate-2/High Risk MDS).
Categories: Amino Acids, Peptides, and ProteinsVorsetuzumab mafodotin
go.drugbank.com/drugs/DB15352InvestigationalVorsetuzumab mafodotin is under investigation in clinical trial NCT01677390 (A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma).
Categories: Amino Acids, Peptides, and Proteins